Key facts
- It has raised $30K; the latest was Early Stage VC in Jun 2025.
- Notable investors include Thematic Technology Transfer, LifeSciences@Work.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AquaWomb
- ·The full record, as it builds
Funding rounds
No funding rounds for AquaWomb are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AquaWomb
Developer of a perinatal life support platform designed to improve outcomes for extremely premature babies. The company's platform utilizes advanced technology to replicate the protective environment of the womb, supporting the development of vital organs and reducing the risk of lifelong health complications, enabling intensive care units and healthcare providers to increase survival rates and quality of life for premature infants.
- Sector
- Healthcare
- HQ
- Eindhoven, Netherlands
- Employees
- 3
- Website
- aquawomb.eu/
- Ownership
- Privately Held (backing)
AquaWomb doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AquaWomb shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AquaWomb in its N-PORT filings yet. We sweep new filings monthly.